世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

会員登録

マイページ

ハイコンテントスクリーニング(HCS)市場:製品毎(細胞画像・解析システム、フローサイトメトリ、消耗品、ソフトウェア、サービス)、用途毎(第一次・第二次スクリーニング、毒性試験、目標識別・確認)、エンドユーザ毎 - 2022年までの世界市場予測

High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022

 

出版社 出版年月電子媒体価格ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2017年4月US$5,650
シングルユーザライセンス
169 180

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)のハイコンテントスクリーニング(HCS)市場に関する調査レポートです。

The global high-content screening (HCS) market is projected to reach USD 909.0 million by 2022 at a CAGR of 10.3% during the forecast period. The factors expected to drive the growth of the market are cost containment in pharmaceutical R&D, increasing funding for cellular research, and technological advancements in HCS solutions during the forecast period. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. However, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of the instruments are expected to restrain the market growth to a certain extent.

The HCS instruments market accounted for the largest share of HCS market primarily attributed to advances in instrumentation and automation techniques and high prices of the HCS instruments. The software segment is expected to register the highest growth during the forecast period. The growth of this market is attributed to the technological advancements in image acquisition, data analysis, and storage capabilities and the need to obtain information on changes in cell morphology through high-quality images.

North America is the largest market for high-content screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. High R&D expenditure, the presence of major pharmaceutical market players, and increasing government support are some of the factors contributing to the large share of North America in the market. However, the Asia-Pacific market is expected to register the highest growth during the forecast period owing to increased research in drug discovery, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure.

The major players in the high-content screening market are GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), and Becton, Dickinson and Company (U.S.). Some of the other leading players in this market include Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).

Research Coverage:

The market is segmented based on product, application, end user, and region. Based on product, the market is segmented into high-content screening instruments (cell imaging & analysis systems and flow cytometers), consumables (reagents & assay kits, microplates and other consumables), software, services, and accessories. Based on application, the market is segmented into target identification and validation, primary and secondary screening, toxicity studies, and compound profiling. On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, academic and government institutes, and contract research organizations. This report also provides market information on North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

These regions are further segmented at a country level.

Reasons to Buy the Report

This report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies to strengthen their market shares.

This report provides insights on the following pointers:

- Market Penetration: Comprehensive information on product portfolios offered by the top players in the high-content screening market. This report analyzes the market by product, application, end user, and region
- Product Development/Innovation: Detailed insights on the upcoming trends and product launches in the high-content screening market
- Market Development: Comprehensive information on the lucrative emerging markets for high-content screening
- Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the high-content screening market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and technological capabilities of the leading players in the high-content screening market



目次

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.4 YEARS CONSIDERED FOR THE STUDY 19
1.5 LIMITATIONS 19
1.6 CURRENCY 19
1.7 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH APPROACH 20
2.2 MARKET SIZE ESTIMATION 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3.1 DATA FROM SECONDARY SOURCES 25
2.3.2 DATA FROM PRIMARY SOURCES 25
2.3.3 KEY INDUSTRY INSIGHTS 26
2.4 ASSUMPTIONS FOR THE STUDY 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 32
4.1 HIGH-CONTENT SCREENING: MARKET SNAPSHOT 32
4.2 EUROPE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION (2016) 33
4.3 GEOGRAPHIC SNAPSHOT OF THE HIGH-CONTENT SCREENING MARKET 34
4.4 HIGH-CONTENT SCREENING MARKET: REGIONAL MIX 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 KEY MARKET DYNAMICS 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Need for cost containment in pharmaceutical R&D 38
5.2.1.2 Government funding and venture capital investments across developed markets 39
5.2.1.3 Advancements in informatics solutions and imaging instruments 39
5.2.2 MARKET RESTRAINTS 40
5.2.2.1 Lower adoption of HCS instruments due to their high prices 40
5.2.3 MARKET OPPORTUNITIES 41
5.2.3.1 Increasing number of CROs providing HCS services 41
5.2.3.2 Application of HCS in personalized medicine 41
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Dearth of knowledgeable and skilled operators of HCS instruments 42
5.2.4.2 Inadequate infrastructure and funding for R&D in emerging countries 42

6 INDUSTRY INSIGHTS 44
6.1 INDUSTRY TRENDS 44
6.1.1 RISING ADOPTION OF LABEL-FREE TECHNOLOGIES 44
6.1.2 GROWING FOCUS ON STEM CELL ANALYSIS 44
6.2 TECHNOLOGICAL ROADMAP 45

7 GLOBAL HIGH-CONTENT SCREENING MARKET, BY PRODUCT 47
7.1 INTRODUCTION 48
7.2 INSTRUMENTS 49
7.2.1 CELL IMAGING AND ANALYSIS SYSTEMS 51
7.2.2 FLOW CYTOMETERS 52
7.2.2.1 Cell analyzers 54
7.2.2.2 Cell sorters 55
7.3 CONSUMABLES 56
7.3.1 REAGENTS & ASSAY KITS 57
7.3.2 MICROPLATES 58
7.3.3 OTHER CONSUMABLES 59
7.4 SOFTWARE 60
7.5 SERVICES 61
7.6 ACCESSORIES 62

8 GLOBAL HIGH-CONTENT SCREENING MARKET, BY APPLICATION 63
8.1 INTRODUCTION 64
8.2 PRIMARY AND SECONDARY SCREENING 65
8.3 TARGET IDENTIFICATION AND VALIDATION 66
8.4 TOXICITY STUDIES 67
8.5 COMPOUND PROFILING 68
8.6 OTHER APPLICATIONS 69

9 GLOBAL HIGH-CONTENT SCREENING MARKET, BY END USER 70
9.1 INTRODUCTION 71
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 72
9.3 ACADEMIC AND GOVERNMENT INSTITUTES 73
9.4 CONTRACT RESEARCH ORGANIZATIONS 74

10 HIGH-CONTENT SCREENING MARKET, BY REGION 75
10.1 INTRODUCTION 76
10.2 NORTH AMERICA 78
10.2.1 U.S. 81
10.2.2 CANADA 83
10.3 EUROPE 85
10.3.1 GERMANY 89
10.3.2 U.K. 91
10.3.3 FRANCE 93
10.3.4 SWITZERLAND 95
10.3.5 REST OF EUROPE 97
10.4 ASIA-PACIFIC 99
10.4.1 JAPAN 103
10.4.2 CHINA 105
10.4.3 INDIA 107
10.4.4 REST OF ASIA-PACIFIC 109
10.5 LATIN AMERICA 112
10.6 MIDDLE EAST AND AFRICA 114

11 COMPETITIVE LANDSCAPE 117
11.1 OVERVIEW 117
11.2 COMPETITIVE ANALYSIS 118
11.2.1 MARKET PLAYERS RANKING 118
11.2.2 PRODUCT MATRIX 120
11.2.3 VENDOR BENCHMARKING 121
11.3 COMPETITIVE SITUATIONS AND TRENDS 123
11.3.1 PRODUCT LAUNCHES 124
11.3.2 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 125
11.3.3 ACQUISITIONS 126
11.3.4 EXPANSIONS 127

12 COMPANY PROFILES 128
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION 128
12.2 GE HEALTHCARE 129
12.3 DANAHER CORPORATION 132
12.4 PERKINELMER, INC. 135
12.5 THERMO FISHER SCIENTIFIC INC. 138
12.6 BECTON, DICKINSON AND COMPANY 141
12.7 BIOTEK INSTRUMENTS, INC. 144
12.8 BIO-RAD LABORATORIES, INC. 146
12.9 TECAN GROUP LTD. 148
12.10 YOKOGAWA ELECTRIC CORPORATION 150
12.11 MERCK MILLIPORE 152
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13 APPENDIX 154
13.1 INSIGHTS OF INDUSTRY EXPERTS 154
13.2 DISCUSSION GUIDE 155
13.3 OTHER DEVELOPMENTS 158
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 162
13.6 AVAILABLE CUSTOMIZATIONS 164
13.7 RELATED REPORTS 165
13.8 AUTHOR DETAILS 166


LIST OF TABLES

TABLE 1 MARKET DRIVERS: IMPACT ANALYSIS 40
TABLE 2 MARKET RESTRAINTS: IMPACT ANALYSIS 40
TABLE 3 MARKET OPPORTUNITIES: IMPACT ANALYSIS 41
TABLE 4 MARKET CHALLENGES: IMPACT ANALYSIS 43
TABLE 5 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 48
TABLE 6 GLOBAL HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 49
TABLE 7 GLOBAL HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE,
BY COUNTRY/REGION, 2015-2022 (USD MILLION) 50
TABLE 8 GLOBAL CELL IMAGING AND ANALYSIS SYSTEMS MARKET SIZE,
BY COUNTRY/REGION, 2015-2022 (USD MILLION) 51
TABLE 9 GLOBAL FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 52
TABLE 10 GLOBAL FLOW CYTOMETERS MARKET SIZE, BY REGION/COUNTRY,
2015-2022 (USD MILLION) 53
TABLE 11 GLOBAL CELL ANALYZERS MARKET SIZE, BY REGION/COUNTRY,
2015-2022 (USD MILLION) 54
TABLE 12 GLOBAL CELL SORTERS MARKET SIZE, BY REGION/COUNTRY,
2015-2022 (USD MILLION) 55
TABLE 13 GLOBAL HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 56
TABLE 14 GLOBAL HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE,
BY REGION/COUNTRY, 2015-2022 (USD MILLION) 56
TABLE 15 GLOBAL REAGENTS AND ASSAY KITS MARKET SIZE, BY REGION/COUNTRY,
2015-2022 (USD MILLION) 57
TABLE 16 GLOBAL MICROPLATES MARKET SIZE, BY REGION/COUNTRY,
2015-2022 (USD MILLION) 58
TABLE 17 GLOBAL OTHER CONSUMABLES MARKET SIZE, BY REGION/COUNTRY,
2015-2022 (USD MILLION) 59
TABLE 18 GLOBAL HIGH-CONTENT SCREENING SOFTWARE MARKET SIZE,
BY REGION/COUNTRY, 2015-2022 (USD MILLION) 60
TABLE 19 GLOBAL HIGH-CONTENT SCREENING SERVICES MARKET SIZE,
BY REGION/COUNTRY, 2015-2022 (USD MILLION) 61
TABLE 20 GLOBAL HIGH-CONTENT SCREENING ACCESSORIES MARKET SIZE,
BY REGION/COUNTRY, 2015-2022 (USD MILLION) 62
TABLE 21 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 64
TABLE 22 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE FOR PRIMARY AND SECONDARY SCREENING, BY COUNTRY, 2015-2022 (USD MILLION) 65
TABLE 23 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2015-2022 (USD MILLION) 66
TABLE 24 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE FOR TOXICITY STUDIES,
BY COUNTRY, 2015-2022 (USD MILLION) 67
TABLE 25 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE FOR COMPOUND PROFILING, BY COUNTRY, 2015-2022 (USD MILLION) 68
TABLE 26 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE FOR OTHER APPLICATIONS,
BY COUNTRY, 2015-2022 (USD MILLION) 69
TABLE 27 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 71
TABLE 28 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION) 72
TABLE 29 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE FOR ACADEMIC AND GOVERNMENT INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION) 73
TABLE 30 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015-2022 (USD MILLION) 74
TABLE 31 GLOBAL HIGH-CONTENT SCREENING MARKET, BY REGION,
2015-2022 (USD MILLION) 77
TABLE 32 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET SIZE, BY COUNTRY,
2015-2022 (USD MILLION) 79
TABLE 33 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 79
TABLE 34 NORTH AMERICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE,
BY TYPE, 2015-2022 (USD MILLION) 79
TABLE 35 NORTH AMERICA: FLOW CYTOMETERS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 79
TABLE 36 NORTH AMERICA: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE,
BY TYPE, 2015-2022 (USD MILLION) 80
TABLE 37 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION) 80
TABLE 38 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 80
TABLE 39 U.S.: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 81
TABLE 40 U.S.: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 81
TABLE 41 U.S.: FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 82
TABLE 42 U.S.: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 82
TABLE 43 U.S.: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 82
TABLE 44 U.S.: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 82
TABLE 45 CANADA: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 83
TABLE 46 CANADA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 83
TABLE 47 CANADA: FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 83
TABLE 48 CANADA: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 84
TABLE 49 CANADA: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 84
TABLE 50 CANADA: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 84
TABLE 51 PHARMACEUTICAL R&D EXPENDITURE IN EUROPE, BY COUNTRY,
2014 (USD MILLION) 85
TABLE 52 EUROPE: HIGH-CONTENT SCREENING MARKET SIZE, BY COUNTRY,
2015-2022 (USD MILLION) 87
TABLE 53 EUROPE: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 87
TABLE 54 EUROPE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 87
TABLE 55 EUROPE: FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 87
TABLE 56 EUROPE: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 88
TABLE 57 EUROPE: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 88
TABLE 58 EUROPE: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 88
TABLE 59 GERMANY: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 89
TABLE 60 GERMANY: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 90
TABLE 61 GERMANY: FLOW CYTOMETERS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 90
TABLE 62 GERMANY: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 90
TABLE 63 GERMANY: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 90
TABLE 64 GERMANY: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 91
TABLE 65 U.K.: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 91
TABLE 66 U.K.: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 92
TABLE 67 U.K.: FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 92
TABLE 68 U.K.: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 92
TABLE 69 U.K.: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 92
TABLE 70 U.K.: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 93
TABLE 71 FRANCE: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 93
TABLE 72 FRANCE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 94
TABLE 73 FRANCE: FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 94
TABLE 74 FRANCE: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 94
TABLE 75 FRANCE: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 94
TABLE 76 FRANCE: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 95
TABLE 77 SWITZERLAND: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 95
TABLE 78 SWITZERLAND: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE,
BY TYPE, 2015-2022 (USD MILLION) 96
TABLE 79 SWITZERLAND: FLOW CYTOMETERS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 96
TABLE 80 SWITZERLAND: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE,
BY TYPE, 2015-2022 (USD MILLION) 96
TABLE 81 SWITZERLAND: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 96
TABLE 82 SWITZERLAND: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 97
TABLE 83 REST OF EUROPE: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 97
TABLE 84 REST OF EUROPE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE,
BY TYPE, 2015-2022 (USD MILLION) 98
TABLE 85 REST OF EUROPE: FLOW CYTOMETERS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 98
TABLE 86 REST OF EUROPE: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE,
BY TYPE, 2015-2022 (USD MILLION) 98
TABLE 87 REST OF EUROPE: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION) 98
TABLE 88 REST OF EUROPE: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION) 99
TABLE 89 ASIA-PACIFIC: HIGH-CONTENT SCREENING MARKET SIZE, BY COUNTRY,
2015-2022 (USD MILLION) 101
TABLE 90 ASIA-PACIFIC: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 101
TABLE 91 ASIA-PACIFIC: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 101
TABLE 92 ASIA-PACIFIC: FLOW CYTOMETERS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 101
TABLE 93 ASIA-PACIFIC: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 102
TABLE 94 ASIA-PACIFIC: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 102
TABLE 95 ASIA-PACIFIC: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 102
TABLE 96 JAPAN: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 103
TABLE 97 JAPAN: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 103
TABLE 98 JAPAN: FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 104
TABLE 99 JAPAN: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 104
TABLE 100 JAPAN: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 104
TABLE 101 JAPAN: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 104
TABLE 102 CHINA: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 105
TABLE 103 CHINA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 106
TABLE 104 CHINA: FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 106
TABLE 105 CHINA: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 106
TABLE 106 CHINA: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 106
TABLE 107 CHINA: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 107
TABLE 108 INDIA: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 108
TABLE 109 INDIA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 108
TABLE 110 INDIA: FLOW CYTOMETERS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 108
TABLE 111 INDIA: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 108
TABLE 112 INDIA: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2015-2022 (USD MILLION) 109
TABLE 113 INDIA: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 109
TABLE 114 REST OF ASIA-PACIFIC: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION) 110
TABLE 115 REST OF ASIA-PACIFIC: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 110
TABLE 116 REST OF ASIA-PACIFIC: FLOW CYTOMETERS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 110
TABLE 117 REST OF ASIA-PACIFIC: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 111
TABLE 118 REST OF ASIA-PACIFIC: HIGH-CONTENT SCREENING MARKET SIZE,
BY APPLICATION, 2015-2022 (USD MILLION) 111
TABLE 119 REST OF ASIA-PACIFIC: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION) 111
TABLE 120 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 112
TABLE 121 LATIN AMERICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE,
BY TYPE, 2015-2022 (USD MILLION) 113
TABLE 122 LATIN AMERICA: FLOW CYTOMETERS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 113
TABLE 123 LATIN AMERICA: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE,
BY TYPE, 2015-2022 (USD MILLION) 113
TABLE 124 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION) 113
TABLE 125 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 114
TABLE 126 MIDDLE EAST AND AFRICA: HIGH-CONTENT SCREENING MARKET SIZE,
BY PRODUCT, 2015-2022 (USD MILLION) 114
TABLE 127 MIDDLE EAST AND AFRICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 115
TABLE 128 MIDDLE EAST AND AFRICA: FLOW CYTOMETERS MARKET SIZE, BY TYPE,
2015-2022 (USD MILLION) 115
TABLE 129 MIDDLE EAST AND AFRICA: HIGH-CONTENT SCREENING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 115
TABLE 130 MIDDLE EAST AND AFRICA: HIGH-CONTENT SCREENING MARKET SIZE,
BY APPLICATION, 2015-2022 (USD MILLION) 115
TABLE 131 MIDDLE EAST AND AFRICA: HIGH-CONTENT SCREENING MARKET SIZE,
BY END USER, 2015-2022 (USD MILLION) 116
TABLE 132 GLOBAL HIGH-CONTENT SCREENING MARKET RANKING, BY KEY PLAYER, 2016 118
TABLE 133 HIGH-CONTENT SCREENING MARKET: PRODUCT MATRIX 120
TABLE 134 GROWTH STRATEGY MATRIX (2014-2017) 123
TABLE 135 PRODUCT LAUNCHES, 2014-2017 124
TABLE 136 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2014-2017 125
TABLE 137 ACQUISITIONS, 2014-2017 126
TABLE 138 EXPANSIONS, 2014-2017 127


LIST OF FIGURES

FIGURE 1 GLOBAL HIGH-CONTENT SCREENING MARKET SEGMENTATION 18
FIGURE 2 RESEARCH DESIGN 21
FIGURE 3 BOTTOM-UP APPROACH 22
FIGURE 4 TOP-DOWN APPROACH 23
FIGURE 5 DATA TRIANGULATION METHODOLOGY 24
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 26
FIGURE 7 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE, BY PRODUCT,
2017 VS. 2022 (USD MILLION) 28
FIGURE 8 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE, BY APPLICATION,
2017 VS. 2022 (USD MILLION) 29
FIGURE 9 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2017 VS. 2022 (USD MILLION) 30
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE GLOBAL HIGH-CONTENT SCREENING MARKET 31
FIGURE 11 THE HIGH-CONTENT SCREENING MARKET IS PROJECTED TO WITNESS A
DOUBLE-DIGIT GROWTH RATE IN THE FORECAST PERIOD 32
FIGURE 12 GERMANY COMMANDED THE LARGEST SHARE OF THE EUROPEAN
HIGH-CONTENT SCREENING MARKET IN 2016 33
FIGURE 13 THE U.S. ACCOUNTED FOR THE LARGEST SHARE OF
THE HIGH-CONTENT SCREENING MARKET IN 2016 34
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 35
FIGURE 15 HIGH-CONTENT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 37
FIGURE 16 ESTIMATED PRE-APPROVAL COST OF BRINGING A NEW CHEMICAL OR
BIOLOGICAL ENTITY TO MARKET (USD MILLION) 38
FIGURE 17 R&D EXPENDITURE AS PERCENTAGE OF GDP, 2014 42
FIGURE 18 FOCUS ON STEM CELL ANALYSIS AND LABEL-FREE HCS ARE THE MAJOR TRENDS IN THE MARKET 44
FIGURE 19 HIGH-CONTENT SCREENING: TECHNOLOGICAL EVOLUTION 45
FIGURE 20 INSTRUMENTS DOMINATE THE GLOBAL HIGH-CONTENT SCREENING
MARKET IN 2017 48
FIGURE 21 CELL IMAGING AND ANALYSIS SYSTEMS TO DOMINATE THE HIGH-CONTENT SCREENING INSTRUMENTS MARKET BY 2022 49
FIGURE 22 CELL ANYALYZERS SEGMENT TO REGISTER HIGHEST GROWTH DURING
THE FORECAST PERIOD 52
FIGURE 23 PRIMARY & SECONDARY SCREENING SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE HCS MARKET DURING THE FORECAST PERIOD 64
FIGURE 24 GLOBAL HIGH-CONTENT SCREENING MARKET SIZE, BY END USER,
2017 VS 2022 (USD MILLION) 71
FIGURE 25 GEOGRAPHIC SNAPSHOT: HIGH-CONTENT SCREENING MARKET 76
FIGURE 26 NORTH AMERICA WILL CONTINUE TO DOMINATE THE HIGH-CONTENT SCREENING MARKET BY 2022 77
FIGURE 27 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET SNAPSHOT 78
FIGURE 28 EUROPE: HIGH-CONTENT SCREENING MARKET SNAPSHOT 86
FIGURE 29 ASIA-PACIFIC: HIGH-CONTENT SCREENING MARKET SNAPSHOT 100
FIGURE 30 PRODUCT LAUNCHES WAS THE MOST-PREFERRED STRATEGY BETWEEN
2014 AND 2017 117
FIGURE 31 HIGH-CONTENT SCREENING: VENDOR BENCHMARKING 121
FIGURE 32 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES - THE MOST WIDELY ADOPTED STRATEGY BETWEEN 2014 AND 2017 123
FIGURE 33 GEOGRAPHICAL REVENUE MIX OF THE TOP 5 PLAYERS IN
THE HIGH-CONTENT SCREENING MARKET 128
FIGURE 34 GE HEALTHCARE: COMPANY SNAPSHOT (2016) 129
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2016) 132
FIGURE 36 PERKINELMER, INC.: COMPANY SNAPSHOT (2016) 135
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016) 138
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016) 141
FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016) 146
FIGURE 40 TECAN GROUP LTD.: COMPANY SNAPSHOT (2016) 148
FIGURE 41 YOKOGAWA ELECTRIC CORPORATION: COMPANY SNAPSHOT (2015) 150
FIGURE 42 MERCK MILLIPORE: COMPANY SNAPSHOT (2016) 152
 

 

ページTOPに戻る

同社・類似レポート一覧

プレスリリース

[プレスリリース原文]

High Content Screening Market worth 909.0 Million USD by 2022


April 13, 2017

The report "High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022", The global high-content screening market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%.

The factors expected to drive the growth of the market are rising need for cost containment in pharmaceutical R&D, growth in funding for cellular research, and technological advancements in HCS solutions during the forecast period. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine offer significant growth opportunities in the HCS market. The rising adoption of label-free technologies and growing focus on stem cell analysis are the key trends in the HCS market.

In this report, the market is segmented based on product, application, end user, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets.

In 2016, the instruments segment accounted for the largest share in the HCS market. The large share of this segment is attributed to advanced automation techniques and high prices of HCS instruments. The cell imaging and analysis systems sub-segment accounted for the largest share of the HCS instruments market and is expected to further dominate the market by 2022.

In 2016, the primary & secondary screening segment accounted for the largest share of the high-content screening market, followed by target identification. The primary & secondary screening segment is also projected to register the highest growth during the forecast period. Growth in this segment can be attributed to the presence of a large number of potential drug candidates for target-specific delivery. In addition, in the coming years, the use of HCS in primary screening is expected to increase due to significant improvements in instruments and image acquisition & data analysis software.

In 2016, the pharmaceutical & biotechnology companies segment accounted for the largest share of the high-content screening market, followed by academic & government institutes and contract research organizations. The pharmaceutical & biotechnology companies segment will continue to dominate the market in 2022, with the highest growth rate. Growth in this segment can be attributed to the widespread use of HCS in preclinical and clinical studies in pharmaceutical and biotechnology industries.

In 2016, North America dominated the global market. High R&D expenditure, the presence of major pharmaceutical market players, and increasing government support are some of the factors driving the growth of the HCS market in this region.

The prominent players in the global high-content screening market are GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問い合せは、お電話・メール・WEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問い合せはこちらのフォームから承ります

office@dri.co.jp

 

ページTOPに戻る